


27541
Merck - Prestige V + WNV is a killed vaccine that protects healthy horses 6 months of age or older against Equine Encephalomyelitis Eastern and Western, equine Herpesviruses(Rhino) EHV-1 and EHV-4, and Equine Influenza virus subtypes A1, A2 including KY93, KY02, and Tetanus Toxoid Plus West Nile.
Single dose w/syringe and needle
Â
Prestige V + WNV is a killed vaccine that protects healthy horses 6 months of age or older against Equine Encephalomyelitis Eastern and Western, equine Herpesviruses(Rhino) EHV-1 and EHV-4, and Equine Influenza virus subtypes A1, A2 including KY93, KY02, and Tetanus Toxoid Plus West Nile. Prestige V + WNV with Havlogen Equine Vaccine is a combination of inactivated, concentrated, adjuvanted, tissue culture origin Equine Encephalomyelitis Viruses (Eastern and Western), Equine Herpesviruses (Rhino EHV-1 and EHV-4), Equine Influenza Viruses (EIV A/Equine 2/Kentucky/93 [H3N8] American, EIV A/Equine 2/Kentucky/02 [H3N8] American, EIV A/Equine 2/Newmarket/2/93 [H3N8] Eurasian), West Nile Virus - Flavivirus Chimera and Tetanus Toxoid. Killed virus.
FEATURES / BENEFITS
Prestige® V + WNV with Havlogen® is recommended for the prevention and aid of equine Eastern and Western Encephalomyelitis, EIV, EHV-1, EHV-4, West Nile Virus, and Tetanus
Formulated for maximum protection
Killed virus
Injectable vaccination
Made in the USA
SPECIFICATIONS
Single dose w/syringe and needle
INSTRUCTIONS
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3Â -Â 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.